Pfizer Inc. Sales Lag, Hurt By Dollar, Generic Lipitor
NEW YORK Nov 2 (Reuters) - Pfizer Inc (PFE.N) reported sales far below Wall Street forecasts on Tuesday, hurt by the stronger dollar and generic competition in international markets for cholesterol fighter Lipitor.